// App-Quantinova.ai

4843 : A next generation sequencing (NGS) genome wide copy number variation (CNV) assay for comparison of circulating tumor cell (CTC) heterogeneity

Researchers

Presenter

  • Stephanie Green

Principal Investigators

  • Mark Landers

  • Jessica Louw

  • Adam Jendrisak

  • Ryan Dittamore

  • Dena Marrinucci

Medical Centers

  • Epic Sciences, Inc., San Diego, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved